Navigation Links
Multiple Screening Strategy Boosts Cervical Cancer Detection
Date:1/13/2009

Two extra steps improve results, study finds

TUESDAY, Jan. 13 (HealthDay News) -- Two extra steps may improve the accuracy of cervical cancer screening, a new study claims.

A Pap smear is the standard test, but findings in the Jan. 13 online issue of the Journal of the National Cancer Institute call for patients to get human papillomavirus (HPV) DNA testing first and then again after the Pap smear if they have HPV infections.

The study, led by Dr. Joakim Dillner of Lund University in Sweden, found this screening approach improved detection of precancerous growths with minimal increase in false-positive tests.

In tests done on more than 6,200 women, those found to have HPV infections through the primary screening went on to have a standard Pap test; those with normal Pap smears were given a repeat HPV DNA test at least one year later. The method found 30 percent more cases of cervical cancer, but with only 12 percent more tests required.

More information

The U.S. National Cancer Institute has more about cervical cancer.



-- Kevin McKeever



SOURCE: Journal of the National Cancer Institute, news release, Jan. 13, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Merck Serono and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis
2. Team Designs Gold Nanoparticles to Deliver Multiple Drugs
3. New Website, MyFoodMyHealth, Helps People Manage Multiple Health Conditions Using Delicious Food
4. Multiple Doses of Steroids Dont Help Preemies
5. Cognition Pharmaceuticals Announces Positive Memory Results for Phase II Trial of C105 in Multiple Sclerosis
6. Combo Therapy Helps Multiple Myeloma Patients
7. Multiple ICD Replacements Can Predict Complications
8. Drug combination improves or stabilizes disease for relapsed multiple myeloma patients
9. Researchers & Department of Defense Question Multiple Vaccine Administration
10. Brooks Kushman Stomps on Multiple Sclerosis: Local Law Firm Honored by Multiple Sclerosis Society for Fundraising Efforts
11. Insurers Employ Multiple Solutions to Avoid Radiology Expense Spike
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... With ... pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation Center is ... of successfully certified products, services and staff. , Validation Center is ISO17025 accredited ...
(Date:5/26/2016)... DC (PRWEB) , ... May 26, 2016 , ... There ... National Hot Dog and Sausage Council (NHDSC) suggests that Americans prefer their dogs straight ... dogs, 63 percent say grilling is their favorite way to cook a hot dog, ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... discovery of thousands of defective respirators, according to court documents and SEC filings. ... of William and Becky Tyler v. American Optical Corporation, Case No. BC588866, Los ...
(Date:5/26/2016)... ... May 26, 2016 , ... Georgia State University ... specialty academic programs. , Answering to the increasing demand for curricular specializations, the ... law, and environmental and land use law. ,  , “The demand for lawyers ...
(Date:5/26/2016)... ... ... On Memorial Day, Hope For Heroes and USA Medical Card will ... country. The nonprofit Hope For Heroes partnered with the leading provider of free ... military veterans, as well as police, firemen, and EMS professionals across the country, and ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... , May 26, 2016 ... Associated With Both Cost Savings and Overall ... plc (LSE: BTG), an international specialist healthcare company, ... at the 21st Annual Meeting of ISPOR (International ... treatment of hepatocellular carcinoma (HCC) using yttrium-90 glass ...
(Date:5/25/2016)... 25,2016 FDA 510(k) clearance ... platform for urological and surgical applications ... of Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) ... the US with the 12 th 510(k) ... (FDA). This new FDA clearance covers Confocal Miniprobes ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
Breaking Medicine Technology: